Mr. Speaker, the five years of funding for prostate cancer research that began in 1999 was a fixed period initiative that provided the necessary boost to increase Canada's capacity in this area.
This government is now taking an integrated approach to cancer control that aims to reduce the incidence, mortality and morbidity of all cancers rather than focusing on a few particular tumour sites. In 2002 the CIHR was created to support health research. In 2003-04 the CIHR allocated almost $8 million to prostate cancer research.